GeneDx Holdings Corp (WGS)
78.71
+6.64
(+9.21%)
USD |
NASDAQ |
Nov 22, 16:00
78.78
+0.07
(+0.09%)
After-Hours: 20:00
GeneDx Holdings Total Liabilities (Quarterly): 204.34M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 204.34M |
June 30, 2024 | 195.06M |
March 31, 2024 | 187.31M |
December 31, 2023 | 190.74M |
September 30, 2023 | 163.03M |
June 30, 2023 | 180.28M |
March 31, 2023 | 216.83M |
Date | Value |
---|---|
December 31, 2022 | 237.24M |
September 30, 2022 | 267.68M |
June 30, 2022 | 296.01M |
March 31, 2022 | 188.23M |
December 31, 2021 | 165.99M |
September 30, 2021 | 212.09M |
December 31, 2020 | 581.69M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
163.03M
Minimum
Sep 2023
581.69M
Maximum
Dec 2020
234.75M
Average
199.70M
Median
Total Liabilities (Quarterly) Benchmarks
Spok Holdings Inc | 60.47M |
Ontrak Inc | 10.94M |
DarioHealth Corp | 51.44M |
National Research Corp | 97.18M |
FOXO Technologies Inc | 60.22M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 408.84M |
Shareholders Equity (Quarterly) | 204.50M |
Debt to Equity Ratio | 0.2544 |
Current Ratio | 2.405 |
Net Debt Paydown Yield | -0.79% |